Fort Collins companies to present at Denver science conference

DENVER – Three Fort Collins companies will present at the 2011 Rocky
Mountain Life Science Investor and Partnering Conference, to be held at
the Brown Palace Hotel, 321 17th St. in Denver Sept. 21 and 22.

KromaTiD Inc., bioscience company focused on the creation of new
products for chromosome analysis; Inviragen Inc., a vaccine development
specialist; and VetDC Inc., which focuses on reverse-engineering human
medicine to help treat animals, were selected to appear at the
conference.

The 30 presenters for the conference are chosen from a pool of more than
50 applicants by a committee of investors, industry experts and
representatives from partnering state bioscience associations.

Investors and strategic partners expected to attend the event are both
private and public companies in the biotech, device, diagnostic and
pharmaceutical sectors.

The conference is presented by the Colorado Bioscience Association, and
is expected to be attended by more than 50 national investment firms.
This is the second time the CBSA has presented the event.

For more information and registration details, visit www.RockyMtnBioInvest.com.

on Facebook on LinkedIn